Trailing Twelve Months Revenue Growth: NuCana plc (NCNA)

Public company logo of NuCana PLC (NCNA)

The high scalability of NuCana plc (NCNA) intellectual property enables the efficient global distribution of therapy. The year-over-year sales volume growth trajectory for the TTM reflects current dynamics, where the actual value equals 0.00. The asset's value depends on the success of clinical trials rather than the economy, ensuring the business remains fully resilient to macro shocks and seasonal fluctuations.

NuCana (NCNA): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

NuCana - analytical breakdowns and key metrics (NCNA)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:nucana.com
Brand item of nucana.com

This indicator measures rolling year revenue dynamics, reflecting the business's ability to convert market demand into actual cash flow. By analyzing the LTM annual change in sales volume, an investor can see the lack of commercial turnover at NuCana plc (NCNA), as the current stage of late-stage clinical trials generates only an increase in operating expenses without actual inflows.

Who NuCana plc competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Corbus Pharma - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) CRDF (cardiffoncology.com)|BYSI: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth BioAtla Corp (BCAB)|Sales Growth YoY (Last Twelve Months) Lixte Biotechnology Holdings, Inc.|CTXR: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) CLRB|Sales Growth YoY (TTM) BioLineRx Corporation (BLRX)|Sales Growth YoY (Last Twelve Months) Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Trailing Twelve Months Sales Growth|KZIA: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Silexion Therapeutics|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)